Clair Health Raises $11.6M for Wearable Hormone Tracker
Friends, sharing a tech update: Stanford alumni launched Clair Health, securing $11.6M.
- What: an aesthetic wearable for continuous monitoring of hormones and inflammation.
- How: a device with 10 biosensors, including a biomagnetic sensor; voice onboarding and a proprietary AI model analyze voice to infer cycle phase.
- Purpose: to aid menstrual disorders and perimenopause, supplying clinicians with objective longitudinal data instead of patient narratives.
- Commercial: beta testing now; full launch in November. Price: $369 plus $9.99/month subscription.
Why it matters: reduces dependence on blood tests and enhances clinical decision-making.
Do you think such devices will transform women's healthcare?
#womenshealth #wearables #AI #healthtech
Clair wearable: announced price and product details
For readers comparing hormone-tracking wearables, the announcement lists a device price of $369 and a subscription of $9.99 per month. These are announced figures from the original update, not a VMTech offer or an independent product review.
What the announced price includes
The post describes Clair as a wearable in beta testing, with a full launch planned for November. It does not specify shipping regions, regulatory status, subscription terms or whether the monthly plan is required for every feature. Prospective buyers should verify these details and the current price before ordering.
- Announced device price: $369.
- Announced subscription price: $9.99 per month.
- Beta testing was underway when the update was published.
- The full launch was planned for November.
What the Clair wearable is designed to track
According to the announcement, the wearable combines 10 biosensors, including a biomagnetic sensor, to monitor hormones and inflammation continuously. It also describes voice onboarding and a proprietary AI model that analyzes voice signals to infer cycle phase. The stated purpose is to provide longitudinal data related to menstrual disorders and perimenopause for discussion with clinicians.
- The announced design includes 10 biosensors.
- Continuous hormone and inflammation monitoring is the stated goal.
- Voice analysis is described as one input for estimating cycle phase.
- The post presents the device as a source of longitudinal health data.
Frequently asked questions
What is the announced price of the Clair hormone tracker?
The announcement lists a price of $369 for the wearable, plus a $9.99 monthly subscription. Current pricing and subscription conditions should be confirmed before purchase.
Is the Clair wearable available now?
The original update says the product was in beta testing and that a full launch was planned for November. It does not provide confirmed regional availability or shipping details.
What does the Clair wearable monitor?
The announcement describes continuous monitoring of hormones and inflammation through 10 biosensors. It also mentions voice analysis intended to infer cycle phase.
Is this an independent medical review of Clair?
No. This page summarizes a technology announcement and does not independently assess clinical effectiveness, regulatory status or suitability for an individual user.